Company Filing History:

12 out of 101

R.p. Scherer Corporation

patents

4 out of 117

R.p.scherer Technologies, Inc.

patents

Years Active: 1995-2015

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9192580 - Fast-dispersing dosage forms containing fish gelatin (2015-11-24),

2. 6726928 - Process for preparing solid dosage forms for unpalatable pharmaceuticals (2004-04-27),

3. 6709669 - Fast-dispersing dosage forms containing fish gelatin (2004-03-23),

4. 6509040 - Fast dispersing dosage forms essentially free of mammalian gelatin (2003-01-21),

5. 6423342 - Process for the preparation of a solid pharmaceutical dosage form (2002-07-23),

6. 6413549 - Fast-Dispersing solid oral dosage form containing coarse particles (2002-07-02),

7. 6391237 - Formation of indicia in the base of a blister pack for transference to a body cast therein (2002-05-21),

8. 6212791 - Method of applying indicia to a fast-dissolving dosage form (2001-04-10),

9. 6156339 - Process for preparing solid pharmaceutical dosage forms (2000-12-05),

10. 5976577 - Process for preparing fast dispersing solid oral dosage form (1999-11-02),

11. 5837287 - Process for preparing solid pharmaceutical dosage forms (1998-11-17),

12. 5827541 - Process for preparing solid pharmaceutical dosage forms of hydrophobic (1998-10-27),

13. 5738875 - Process for preparing solid pharmaceutical dosage forms (1998-04-14),

14. 5729958 - Method for manufacturing freeze dried dosages in a multilaminate blister (1998-03-24),

15. 5631023 - Method for making freeze dried drug dosage forms (1997-05-20),

Title: Innovator Patrick Kearney: Advancing Pharmaceutical Innovations from Swindon

Introduction

Patrick Kearney, an accomplished inventor based in Swindon, Great Britain, has made significant contributions to the field of pharmaceuticals through his impressive portfolio of 16 patents. His work focuses on developing innovative dosage forms that aim to improve patient experience and medication compliance.

Latest Patents

Among his latest patents are groundbreaking inventions that utilize fish gelatin as a carrier in fast-dispersing dosage forms. The composition disclosed in one patent is designed to enable rapid release of the active ingredient upon contact with fluids, particularly beneficial for oral administration. This invention specifically employs fish gelatin from cold water sources, presenting a non-gelling, non-hydrolyzed form that enhances the dispersal of pharmaceutical compounds.

Another notable patent outlines a process for creating solid dosage forms for unpalatable pharmaceuticals. This process addresses the challenge of unpalatable active ingredients by formulating a solution or suspension that is both more palatable and water-soluble. This innovative method significantly enhances medication adherence, particularly in populations sensitive to taste.

Career Highlights

Patrick Kearney has had a commendable career, holding positions at prominent companies such as R.P. Scherer Corporation and R.P. Scherer Technologies, Inc. Throughout his tenure, he has consistently focused on pushing the boundaries of pharmaceutical formulations, resulting in numerous patents that have had a tangible impact on the industry.

Collaborations

Throughout his career, Kearney has collaborated with talented individuals, including Andrew R. Thompson and Richard J. Yarwood. These partnerships have facilitated the sharing of ideas and expertise, further enriching his innovative contributions to pharmaceutical sciences.

Conclusion

In summary, Patrick Kearney's contributions to the field of pharmaceuticals, particularly through his recent inventions, demonstrate his commitment to innovation and improving patient care. With a firm foundation in research and development, Kearney continues to be a driving force in the evolution of dosage forms that enhance accessibility and efficacy in medication delivery.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com